We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
-1.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$196M
AUM Growth
-$3.16M
(-1.6%)
Cap. Flow
+$648K
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
97
New
–
Increased
34
Reduced
26
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.12M |
| 2 |
Procter & Gamble
PG
|
+$434K |
| 3 |
iShares Biotechnology ETF
IBB
|
+$394K |
| 4 |
ExxonMobil
XOM
|
+$342K |
| 5 |
GE Aerospace
GE
|
+$326K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.87M |
| 2 |
AbbVie
ABBV
|
+$426K |
| 3 |
Union Pacific
UNP
|
+$351K |
| 4 |
VanEck Biotech ETF
BBH
|
+$315K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$298K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Industrials | 14.39% |
| 3 | Healthcare | 11.95% |
| 4 | Financials | 11.2% |
| 5 | Consumer Staples | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kimberly-Clark
KMB
$36.3B
| $415K | 0.21% |
3,775
| – | – |
|
77
PPG Industries
PPG
$24.6B
| $412K | 0.21% |
3,700
| – | – |
|
78
Illinois Tool Works
ITW
$82.6B
| $404K | 0.21% |
2,580
| – | – |
|
79
Emerson Electric
EMR
$83.9B
| $394K | 0.2% |
5,780
| – | – |
|
80
Yum! Brands
YUM
$41.8B
| $380K | 0.19% |
4,468
| – | – |
|
81
Eli Lilly
LLY
$1.02T
| $372K | 0.19% |
4,815
| – | – |
|
82
Alerian MLP ETF
AMLP
$13B
| $328K | 0.17% |
7,005
-400
| -5% | -$21.4K |
|
83
DuPont de Nemours
DD
$18.5B
| $325K | 0.17% |
2,015
| – | – |
|
|
MNDT
84
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $319K | 0.16% |
18,900
| – | – |
|
85
Waste Management
WM
$90.6B
| $301K | 0.15% |
3,580
| – | – |
|
|
86
Wells Fargo
WFC
$261B
| $298K | 0.15% |
5,705
-48,324
| -89% | -$2.87M |
|
87
VF Corp
VFC
$5.63B
| $256K | 0.13% |
3,675
| – | – |
|
88
Southern Company
SO
$109B
| $243K | 0.12% |
5,450
+700
| +15% | +$31.1K |
|
89
Danaher
DHR
$137B
| $236K | 0.12% |
2,726
| – | – |
|
90
iShares MSCI EAFE ETF
EFA
$78B
| $228K | 0.12% |
3,286
| – | – |
|
|
MRSH
91
Marsh
MRSH
$90.5B
| $216K | 0.11% |
2,620
| – | – |
|
92
Genuine Parts
GPC
$17.1B
| $214K | 0.11% |
2,390
| – | – |
|
93
Texas Instruments
TXN
$252B
| $214K | 0.11% |
2,060
| – | – |
|
94
Clorox
CLX
$11.6B
| $212K | 0.11% |
1,595
| – | – |
|
95
Amgen
AMGN
$208B
| $201K | 0.1% |
1,180
| – | – |
|
96
Occidental Petroleum
OXY
$56.8B
| – | – |
-2,980
| Closed | -$219K |
|
|
97
Union Pacific
UNP
$174B
| – | – |
-2,620
| Closed | -$351K |
|
Similar funds
SCV
TFP
MG
HWMG
AI
IMA
CMHI
RS
Boston Research & Management's Q1 2018 Portfolio in Review
As of Q1 2018, Boston Research & Management held 97 positions worth $196M, down 1.6% from $199M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 2.1%. Boston Research & Management opened no new positions and exited 2, leaving the 97-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Boston Research & Management added most to Merck in Q1 2018, an estimated $2.12M increase.
- Boston Research & Management's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $2.87M.
- Boston Research & Management fully exited Union Pacific in Q1 2018, selling an estimated $351K.
- Boston Research & Management's ten largest holdings make up 25% of its $196M portfolio in Q1 2018.
- Boston Research & Management opened 0 new positions and closed 2 in Q1 2018.
- Boston Research & Management's portfolio value fell 1.6% quarter-over-quarter to $196M.
Based on Boston Research & Management's 13F filing for Q1 2018, filed 9 May 2018.